Price movement over the last 24 hours
Samcro Hyosung Adilestari Tbk. vs Merck Tbk. — how do they compare? Samcro Hyosung Adilestari Tbk. trades at Rp60 (market cap 208.16B, 9.55M 24h volume), while Merck Tbk. trades at Rp3,730 (market cap 1.65T, 60.4K 24h volume). The key difference: Merck Tbk. is far larger — about 7.9× Samcro Hyosung Adilestari Tbk.'s market cap, and Samcro Hyosung Adilestari Tbk. is more actively traded (9.55M versus 60.4K). Which is the better fit depends on your goals.
| ACRO | MERK | |
|---|---|---|
Market Cap | 208.16B | 1.65T |
Volume | 9.55M | 60.4K |
Lot | 95.5K | 604 |
Turnover | 587.56M | 223.42M |
Average Price | 61.52 | 3,698.92 |
Value | 587.56M | 223.42M |
Indicative Equilibrium Price | 60 | — |
Indicative Equilibrium Volume | 2K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Samcro Hyosung Adilestari Tbk (The Company) was established on Republic of Indonesia based on Deed of Establishment No. 265 dated July 21, 1989 by Yudo Paripurno, S.H., Notary in Jakarta.
Read more on ACRO →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →